Prothrombin complex concentrate - SanquinAlternative Names: Cofact
Latest Information Update: 13 Dec 2007
At a glance
- Originator Sanquin Blood Supply Foundation
- Class Blood coagulation factors
- Mechanism of Action Factor IX stimulants; Factor VII stimulants; Factor X stimulants; Prothrombin stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Haemorrhage
Most Recent Events
- 12 Nov 2007 Preregistration for Haemorrhage in European Union (IV)